Higashimurayama, Japan

Tsutomu Tohma

This inventor holds 4 USPTO granted patents. Top assignee: Kowa Company Limited. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tsutomu Tohma. Retrieved from https://idiyas.com/inventor/tsutomu-tohma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Tsutomu Tohma: Innovator in Pharmaceutical Chemistry

Introduction

Tsutomu Tohma is a notable inventor based in Higashimurayama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 4 patents. His work focuses on developing innovative compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents, Tohma has developed diamine derivatives and pharmaceutical compositions containing these compounds. One of his notable inventions is a tetrazole derivative, which is represented by a specific chemical formula. This compound is designed to exhibit excellent antileukotriene and antihistaminic activities, making it useful for the prevention and treatment of conditions such as asthma.

Career Highlights

Tohma is currently associated with Kowa Company Limited, where he continues to advance his research in pharmaceutical innovations. His work has been instrumental in creating new medications that address various health issues.

Collaborations

Throughout his career, Tohma has collaborated with esteemed colleagues, including Kazuhiro Onogi and Masahiro Tamura. These partnerships have fostered a collaborative environment that enhances the development of innovative pharmaceutical solutions.

Conclusion

Tsutomu Tohma's contributions to pharmaceutical chemistry exemplify the impact of innovation in healthcare. His patents reflect a commitment to improving medical treatments and addressing critical health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…